Estágio em assuntos regulamentares e farmacovigilância na BlueClinical

Bibliographic Details
Main Author: Barbosa, Manuel Boloto
Publication Date: 2025
Format: Master thesis
Language: eng
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: http://hdl.handle.net/10362/179240
Summary: Abstract: Clinical Research is conducted on either sick or healthy volunteers to stimulate innovation, to improve patient care and enhancement of public health. Clinical Trials are essential for testing the safety and efficacy of new treatments in healthcare. The Clinical Trials Regulation (EU) No 536/2014 came into effect on January 31st, 2022, and it governs Clinical Trials on medicinal products in the European Union and the European Economic Area. It introduced a new framework for the submission and supervision of Clinical Trials and harmonized the conduct of Clinical Trials across the Member States. One of the main objectives of the Regulation is to promote transparency in the sector. Information and essential documentation generated during trial lifecycle will be available in the public domain. One of the exceptions for disclosure is to protect Commercial Confidential Information. Therefore, the Regulation balances scientific advancement and the legitimate commercial interests of Sponsors that invest in the Clinical Trial. This internship report was developed as part of the Master’s Degree in Clinical Research Management and is divided into two sections. The first includes a literary review going over the submission process of Clinical Trials, as well as the transparency requirements and the protection of Commercial Confidential Information. The second section describes the activities performed during the internship in the department of Regulatory Affairs and Pharmacovigilance of the company BlueClinical - Investigação E Desenvolvimento Em Saúde, Lda. The experience cultivated key professional and personal skills and provided a close contact with Clinical Research.
id RCAP_e72fb2bc6f7dd015a6b36f55b543e968
oai_identifier_str oai:run.unl.pt:10362/179240
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Estágio em assuntos regulamentares e farmacovigilância na BlueClinicalClinical ResearchClinical TrialsRegulatory AffairsPharmacovigilanceRegulationCommercial Confidential InformationTransparencySaúdeAbstract: Clinical Research is conducted on either sick or healthy volunteers to stimulate innovation, to improve patient care and enhancement of public health. Clinical Trials are essential for testing the safety and efficacy of new treatments in healthcare. The Clinical Trials Regulation (EU) No 536/2014 came into effect on January 31st, 2022, and it governs Clinical Trials on medicinal products in the European Union and the European Economic Area. It introduced a new framework for the submission and supervision of Clinical Trials and harmonized the conduct of Clinical Trials across the Member States. One of the main objectives of the Regulation is to promote transparency in the sector. Information and essential documentation generated during trial lifecycle will be available in the public domain. One of the exceptions for disclosure is to protect Commercial Confidential Information. Therefore, the Regulation balances scientific advancement and the legitimate commercial interests of Sponsors that invest in the Clinical Trial. This internship report was developed as part of the Master’s Degree in Clinical Research Management and is divided into two sections. The first includes a literary review going over the submission process of Clinical Trials, as well as the transparency requirements and the protection of Commercial Confidential Information. The second section describes the activities performed during the internship in the department of Regulatory Affairs and Pharmacovigilance of the company BlueClinical - Investigação E Desenvolvimento Em Saúde, Lda. The experience cultivated key professional and personal skills and provided a close contact with Clinical Research.Resumo: A Investigação Clínica é realizada em voluntários doentes ou saudáveis para promover a inovação, melhorar os cuidados de saúde aos doentes e reforçar a saúde pública. Os Ensaios Clínicos são essenciais para testar a segurança e eficácia de novos tratamentos na área da saúde. O Regulamento de Ensaios Clínicos (UE) N.º 536/2014 entrou em vigor a 31 de janeiro de 2022 e rege os Ensaios Clínicos com medicamentos na União Europeia e no Espaço Económico Europeu. Este regulamento introduziu um novo enquadramento para a submissão e supervisão de Ensaios Clínicos e harmonizou a condução destes ensaios entre os Estados-Membros. Um dos principais objetivos do Regulamento é promover a transparência no setor. As informações e documentação essencial geradas durante o ciclo de vida de um ensaio estarão disponíveis ao público. Uma das exceções à divulgação é a proteção de Informações Comerciais Confidenciais. Assim, o Regulamento equilibra o avanço científico com os interesses comerciais legítimos dos Promotores que investem no Ensaio Clínico. Este relatório de estágio foi desenvolvido no âmbito do Mestrado em Gestão da Investigação Clínica e está dividido em duas secções. A primeira inclui uma revisão literária sobre o processo de submissão de Ensaios Clínicos, bem como os requisitos de transparência e a proteção de Informações Comerciais Confidenciais. A segunda secção descreve as atividades realizadas durante o estágio no departamento de Assuntos Regulamentares e Farmacovigilância da empresa BlueClinical - Investigação e Desenvolvimento em Saúde, Lda. Esta experiência permitiu desenvolver competências profissionais e pessoais essenciais, proporcionando um contacto próximo com a Investigação ClínicaGago, BrunoRUNBarbosa, Manuel Boloto2025-01-172026-01-17T00:00:00Z2025-01-17T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10362/179240TID:203894260enginfo:eu-repo/semantics/embargoedAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2025-02-24T01:48:38Zoai:run.unl.pt:10362/179240Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T20:40:10.702467Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Estágio em assuntos regulamentares e farmacovigilância na BlueClinical
title Estágio em assuntos regulamentares e farmacovigilância na BlueClinical
spellingShingle Estágio em assuntos regulamentares e farmacovigilância na BlueClinical
Barbosa, Manuel Boloto
Clinical Research
Clinical Trials
Regulatory Affairs
Pharmacovigilance
Regulation
Commercial Confidential Information
Transparency
Saúde
title_short Estágio em assuntos regulamentares e farmacovigilância na BlueClinical
title_full Estágio em assuntos regulamentares e farmacovigilância na BlueClinical
title_fullStr Estágio em assuntos regulamentares e farmacovigilância na BlueClinical
title_full_unstemmed Estágio em assuntos regulamentares e farmacovigilância na BlueClinical
title_sort Estágio em assuntos regulamentares e farmacovigilância na BlueClinical
author Barbosa, Manuel Boloto
author_facet Barbosa, Manuel Boloto
author_role author
dc.contributor.none.fl_str_mv Gago, Bruno
RUN
dc.contributor.author.fl_str_mv Barbosa, Manuel Boloto
dc.subject.por.fl_str_mv Clinical Research
Clinical Trials
Regulatory Affairs
Pharmacovigilance
Regulation
Commercial Confidential Information
Transparency
Saúde
topic Clinical Research
Clinical Trials
Regulatory Affairs
Pharmacovigilance
Regulation
Commercial Confidential Information
Transparency
Saúde
description Abstract: Clinical Research is conducted on either sick or healthy volunteers to stimulate innovation, to improve patient care and enhancement of public health. Clinical Trials are essential for testing the safety and efficacy of new treatments in healthcare. The Clinical Trials Regulation (EU) No 536/2014 came into effect on January 31st, 2022, and it governs Clinical Trials on medicinal products in the European Union and the European Economic Area. It introduced a new framework for the submission and supervision of Clinical Trials and harmonized the conduct of Clinical Trials across the Member States. One of the main objectives of the Regulation is to promote transparency in the sector. Information and essential documentation generated during trial lifecycle will be available in the public domain. One of the exceptions for disclosure is to protect Commercial Confidential Information. Therefore, the Regulation balances scientific advancement and the legitimate commercial interests of Sponsors that invest in the Clinical Trial. This internship report was developed as part of the Master’s Degree in Clinical Research Management and is divided into two sections. The first includes a literary review going over the submission process of Clinical Trials, as well as the transparency requirements and the protection of Commercial Confidential Information. The second section describes the activities performed during the internship in the department of Regulatory Affairs and Pharmacovigilance of the company BlueClinical - Investigação E Desenvolvimento Em Saúde, Lda. The experience cultivated key professional and personal skills and provided a close contact with Clinical Research.
publishDate 2025
dc.date.none.fl_str_mv 2025-01-17
2025-01-17T00:00:00Z
2026-01-17T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10362/179240
TID:203894260
url http://hdl.handle.net/10362/179240
identifier_str_mv TID:203894260
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/embargoedAccess
eu_rights_str_mv embargoedAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833598785169653760